MedTrace Logo

Pain Perception in Alzheimer's Disease

NCT00192816 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2005-09-19

No results posted yet for this study

Summary

The purpose of this study is to determine response to pain in Alzheimer's disease.We plan to study the effect of diffuse noxious inhibitory controls(counterirritation phenomenon)and the autonomic nervous system reaction(reflected by the heart rate) in Alzheimer's disease. The study's hypothesis is that pain perception and autonomic nervous system reaction are altered in Alzheimer's disease.

Conditions

  • Dementia Alzheimer Type

Interventions

BEHAVIORAL

reaction to pain

Sponsors & Collaborators

  • Rambam Health Care Campus

    lead OTHER

Principal Investigators

  • Judith Aharon-Peretz · Rambam Health Care Campus

Eligibility

Min Age
55 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-06-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00192816 on ClinicalTrials.gov